Skip to main content

Therapierichtlinien beim Mammakarzinom

  • Chapter
Book cover Lexikon der Mammadiagnostik

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aberizk W, Silver B, Henderson IC (1986) The use of radiotherapy for treatment of isolated local-regional recurrence of breast cancer after mastectomy, Cancer 58:1214

    Article  PubMed  CAS  Google Scholar 

  2. Abner A, Recht A, Eberlein T et al. (1993) Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early stage breast cancer, J Clin Oncol 11:44

    PubMed  CAS  Google Scholar 

  3. Buchholz TA, Austin-Semour MM, Moe RE (1993) Effect of delay in radiation in the combined modality treatment of breast cancer, Int J Radiat Oncol Biol Phys 26:23–35

    Article  PubMed  CAS  Google Scholar 

  4. Buzzoni R, Bonadonna G, Valagussa P et al. (1991) Adjuvant chemotherapy with doxorubicin plus cyclophosphamid, methotrexate and fluorouracil in the treatment of resectable breast cancer with more than three axillary nodes, J Clin Oncol 9:2134

    PubMed  CAS  Google Scholar 

  5. Chen K, Montague E, Oswald M (1986) Results of irradiation in the treatment of loco-regional breast cancer recurrence, Cancer 56:1269–1273

    Article  Google Scholar 

  6. Clarke D, Martinez A (1992) Identification of patients who are at high risk for locoregional breast cancer recurrence after conservative surgery and radiotherapy: a review article for surgeons, pathologists and radiation and medical oncologists, J Clin Oncol 10:474

    PubMed  CAS  Google Scholar 

  7. Cuzick J, Steward H, Peto R et al. (1994) Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer, Cancer Treat Rep 71:15

    Google Scholar 

  8. Cuzick J, Steward H, Rutquist L et al. (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy, J Clin Oncol 12:447–453

    PubMed  CAS  Google Scholar 

  9. Di Saia PJ, Creasman WT (1997) Breast diseases. In: Di Saia PJ, Creasman WT (eds) Clinical gynecologic oncology, 5th edn, Mosby, St. Louis

    Google Scholar 

  10. Dimitrov N, Anderson S, Fisher B et al. (1994) Dose intensification and increased total dose of adjuvant chemotherapy for breast cancer (BC): findings from NSABP B22, Proc ASCO 13:64

    Google Scholar 

  11. Early Breast Cancer Trialist Collaborative Group (EBCTCG) (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy. 133 randomized trials involving 31.000 recurrences and 24.000 deaths among 75.000 women, Lancet 339:1–15 and 71–85

    Google Scholar 

  12. Eiermann W, Engel J (1995) Tumoradaptierte Brustkrebschirurgie. In: Sauer H (Hrsg) Mammakarzinom, Ergebnisse von Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München

    Google Scholar 

  13. Fentiman IS, Georgy WM, Richards MA (1994) Effect of menstrual phase on surgical treatment of breast cancer, Lancet 344:402

    Article  PubMed  CAS  Google Scholar 

  14. Fisher B, Anderson S, Fisher E et al. (1991) The significance of local recurrence following lumpectomy, Lancet 338:327

    Article  PubMed  CAS  Google Scholar 

  15. Fisher B, Redmond C (1992) Lumpectomy for breast cancer: an update of NSABP experience, J Natl Cancer Inst Monogr 11:7

    PubMed  Google Scholar 

  16. Fisher B, Constantino J, Redmond C et al. (1989) A randomized clinical trial evaluating tamoxifen in the treatment of patients with node negative breast cancer who have estrogen-receptor-positive tumors, N Engl J Med 320:479

    Article  PubMed  CAS  Google Scholar 

  17. Fisher B, Redmond C, Legault-Poisson S et al. (1990) Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the NSABP B16, J Clin Oncol 8:1005

    PubMed  CAS  Google Scholar 

  18. Fisher B, Wolmark N, Bauer M et al. (1981) The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet 152:765

    PubMed  CAS  Google Scholar 

  19. Fisher B, Slack NH, Cavanaugh PJ et al. (1970) Postoperative radiotherapy in the treatment of breast cancer: results of the National Surgical Adjuvant Breast Project Clinical Trial, Ann Surg 172:711–732

    Article  PubMed  CAS  Google Scholar 

  20. Fornander T, Cedermark B, Mattsson A et al. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers, Lancet 1:117

    Article  PubMed  CAS  Google Scholar 

  21. Fowble BL, Solin LJ, Schultz D et al. (1991) Ten year results of conservative surgery and irradiation for Stage I and II breast cancer, Int J Radiat Oncol Biol Phys 21:269–277

    Article  PubMed  CAS  Google Scholar 

  22. Gage I, Recht A, Gelman R et al. (1995) Long term outcome following breast conserving surgery and radiation therapy, Int J Radiat Oncol Biol Phys 33:245–251

    Article  PubMed  CAS  Google Scholar 

  23. Halverson KJ, Taylor ME, Perez CA et al. (1993) Regional nodal management and patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer, Int J Radiat Oncol Biol Phys 26:593–599

    Article  PubMed  CAS  Google Scholar 

  24. Jänicke F (1995) Adjuvante Hormon- und Chemotherapie des Mammakarzinoms. In: Sauer H (Hrsg) Mammakarzinom. Ergebnisse der Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München

    Google Scholar 

  25. Kematsu M, Bornstein B, Recht A et al. (1993) Long term results of postoperative radiation therapy following mastectomy with and without chemotherapy in stage I–III breast cancer, Int J Radiat Oncol Biol Phys 25:765

    Article  Google Scholar 

  26. Kreienberg R, Möbius V (1996) Adjuvante Chemotherapie des nodal negativen Mammakarzinoms, Gynäkologe 29:233–241

    Google Scholar 

  27. Kreienberg R, Schneider V (1996) Carcinoma of the breast. In: Sevin BU, Knapstein PG, Köchli OR (eds) Multimodality therapy in gynecologic oncology, Thieme-Verlag, Stuttgart New York

    Google Scholar 

  28. Kurtz JM (1989) Local recurrence after breast conserving surgery and radiotherapy: frequency, time course and prognosis, Cancer 63:1912–1917

    Article  PubMed  CAS  Google Scholar 

  29. Lichter AS, Lippman ME, Danforth DN et al. (1992) Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial of the National Cancer Institute, J Clin Oncol 10:976–983

    PubMed  CAS  Google Scholar 

  30. Lindner H (1995) Kontroverses zur Radiotherapie bei der brusterhaltenden Behandlung des Mammakarzinoms. In: Sauer H (Hrsg) Mammakarzinom. Ergebnisse der Diagnostik, Therapie und Nachsorge 3, Zuckschwerdt-Verlag, München, S. 27–37

    Google Scholar 

  31. Love RR, Cameron L, Connell BL et al. (1991) Symptoms associated with tamoxifen treatment in postmenopausal women, Arch Intern Med 151:1842

    Article  PubMed  CAS  Google Scholar 

  32. Ludwig Breast Cancer Study Group (1989) Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer, N Engl J Med 320:491

    Article  Google Scholar 

  33. McGuire WL, Clark GM (1992) Prognostic factors and treatment decisions in axillary node-negative breast cancer, N Engl J Med 326:1756

    Article  PubMed  CAS  Google Scholar 

  34. Marchant DJ (1997) Invasive breast cancer: Surgical treatment alternatives. In: Marchant DJ (ed) Breast disease, Saunders, Philadelphia

    Google Scholar 

  35. Osborne CK, Clark GM, Ravdin PM (1996) Adjuvant systemic therapy of primary breast cancer. In: Harris JR, Lippman ME, Morrow M, Heilman S (eds). Diseases of the breast, Lippincott-Raven, Philadelphia

    Google Scholar 

  36. Recht A, Come SE, Harris JR (1992) Integration of conservative surgery, radiotherapy and chemotherapy for patients with early-stage breast cancer, Semin Radiat Oncol 2:107–115

    Article  PubMed  Google Scholar 

  37. Recht H, Houlinan MJ (1995) Axillary lymph nodes and breast cancer, Cancer 76:1491–1512

    Article  PubMed  CAS  Google Scholar 

  38. Rivkin SE, Green S, Metch B et al. (1994) Adjuvant CMFVP versus tamoxifen versus CMFVP and tamoxifen for postmenopausal, node positive and estrogen receptor positive breast cancer patients: a Southwest Oncology Group Study, J Clin Oncol 12:2078

    PubMed  CAS  Google Scholar 

  39. Rutquist L, Petterson D, Johannsen M (1993) Adjuvant radiation therapy versus surgery alone in operable breast cancer: long term follow up in a randomized clinical trial, Radiat Oncol 26:104

    Article  Google Scholar 

  40. Rutquist L, Cedermark B, Glas U et al. (1989) Radiotherapy, chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials, Int J Radiat Oncol Biol Phys 16:629–633

    Article  Google Scholar 

  41. Sarrazin D, Le MG, Arriagada R et al. (1989) Ten year results of a randomized trial comparing a conservative treatment ot mastectomy in early breast cancer, Rad Oncol 14:177–184

    Article  CAS  Google Scholar 

  42. Schmidt-Mathiesen H, Bastert G (1993) Mammakarzinom. In: Schmidt-Mathiesen H, Bastert G (Hrsg) Gynäkologische Onkologie, 4. Aufl., Schattauer-Verlag, Stuttgart New York

    Google Scholar 

  43. Schnürch HG (1991) Medikamentöse Therapie bei Mammakarzinomerkrankungen. In: Bender HG (Hrsg) Gynäkologische Onkologie, Thieme-Verlag, Stuttgart New York, S. 377–423

    Google Scholar 

  44. Scottish Cancer Trials Breast Group and ICFR Breast Unit, Guy’s Hospital (1993) Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: The Scottish Trial, Lancet 341:1293

    Google Scholar 

  45. Snacks NPM, Baum M (1993) Primary management of carcinoma of the breast, Lancet 342:1402–1408

    Article  Google Scholar 

  46. Valagussa P, Bonadonna G, Veronesi U (1978) Pattern of relapse and survival following radical mastectomy: analysis of 716 consecutive patients, Cancer 41:1170–1179

    Article  PubMed  CAS  Google Scholar 

  47. Veronesi U, Luini A, Galimberti V et al (1994) Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials, World J Surg 18:70

    Article  PubMed  CAS  Google Scholar 

  48. Wazer DE (1997) Radiation therapy in the management of early invasive breast cancer. In: Marchand DJ (ed) Breast disease, WB Saunders, Philadelphia

    Google Scholar 

  49. Weyland C (1996) Aktuelle Aspekte der Therapie des Mammakarzinoms. Symposiumsbericht, 22. Deutscher Krebskongreß, Berlin, Februar 1996. Gyn Spektrum 2:7–9

    Google Scholar 

  50. Wood WC, Budman DR, Korzun AH et al. (1994) Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast cancer, N Engl J Med 300:1253

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pietschmann, D., Pietschmann, V. (1998). Therapierichtlinien beim Mammakarzinom. In: Lexikon der Mammadiagnostik. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72101-4_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72101-4_48

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-63969-5

  • Online ISBN: 978-3-642-72101-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics